STAT+: A Celldex treatment induces symptom relief in patients with chronic hives
An experimental drug from Celldex Therapeutics induced complete symptom relief in half of patients with chronic and severe hives — study results that are still preliminary but suggest a new way to tamp down immune reactions that can trigger the debilitating skin condition.
The new data also validate Celldex’s strategic decision, taken two years ago, to pivot to treatments for autoimmune disease, following multiple setbacks with cancer therapies.
Continue to STAT+ to read the full story…
